NewEdge Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.74M | Buy |
|
|||||
|
2025
Q1 | $3.51M | Buy |
|
|||||
|
2024
Q4 | $2.82M | Buy |
|
|||||
|
2024
Q3 | $3.08M | Buy |
|
|||||
|
2024
Q2 | $2.7M | Buy |
|
|||||
|
2024
Q1 | $1.85M | Buy |
|
|||||
|
2023
Q4 | $1.56M | Buy |
|
|||||
|
2023
Q3 | $1.41M | Buy |
|
|||||
|
2023
Q2 | $913K | Buy |
|
|||||
|
2023
Q1 | $810K | Sell |
|
|||||
|
2022
Q4 | $324K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $968K | Sell |
|
|||||
|
2022
Q1 | $1.09M | Buy |
|
|||||
|
2021
Q4 | $830K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $229K | Sell |
|
|||||
|
2020
Q1 | $565K | Buy |
|
|||||
|
2019
Q4 | $318K | Buy |
|
|||||
|
2019
Q3 | $286K | Buy |
|
|||||
|
2019
Q2 | $232K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $284K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $87.5K | Buy |
|